» Articles » PMID: 15117448

CD8+CD38+ T Cells but Not HIV Type 1 RNA Viral Load Predict CD4+ T Cell Loss in a Predominantly Minority Female HIV+ Adolescent Population

Overview
Publisher Mary Ann Liebert
Date 2004 May 1
PMID 15117448
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to evaluate predictors of HIV-1 disease progression in a cohort of predominantly female and minority adolescents who had acquired their HIV-1 infections through sexual risk behaviors. Subjects were identified from the REACH cohort who were not on antiretroviral therapy for at least 1 year and whose baseline CD4(+) T cells were >300 cells/mm(3). Biomedical and demographic characteristics of the subjects at the start of the study period were evaluated as predictors of CD4(+) T cell loss in univariate and multivariate models. Two-thirds of the 99 subjects meeting the selection criteria were female and 87% were black or Hispanic similar to the REACH cohort as a whole. Higher absolute CD8(+) CD38(+) T cell counts at the start of the assessment period were associated with a greater rate of loss of CD4(+) T cells. HIV-1 RNA viral load was among other potential predictors of HIV-1 disease progression that had no association with the rate of CD4(+) T cell loss in this cohort. This study extends the observed association of higher CD8(+) CD38(+) T cells numbers being predictive of HIV-1 disease progression into predominantly female, minority youth.

Citing Articles

IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.

Younes S, Freeman M, Mudd J, Shive C, Reynaldi A, Panigrahi S J Clin Invest. 2016; 126(7):2745-56.

PMID: 27322062 PMC: 4922693. DOI: 10.1172/JCI85996.


Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.

Rudy B, Kapogiannis B, Worrell C, Squires K, Bethel J, Li S J Acquir Immune Defic Syndr. 2015; 69(1):52-60.

PMID: 25942459 PMC: 4452031. DOI: 10.1097/QAI.0000000000000549.


Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infection.

Shankar E, Velu V, Kamarulzaman A, Larsson M World J Virol. 2015; 4(1):17-24.

PMID: 25674514 PMC: 4308524. DOI: 10.5501/wjv.v4.i1.17.


Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth.

McGuire J, Kempen J, Localio R, Ellenberg J, Douglas S Clin Vaccine Immunol. 2014; 22(1):27-36.

PMID: 25355798 PMC: 4278930. DOI: 10.1128/CVI.00463-14.


Mitochondrial DNA variation and virologic and immunological HIV outcomes in African Americans.

Aissani B, Shrestha S, Wiener H, Tang J, Kaslow R, Wilson C AIDS. 2014; 28(13):1871-8.

PMID: 24932613 PMC: 5004594. DOI: 10.1097/QAD.0000000000000371.